Page 3 - 31446210 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Veru (NASDAQ:VERU – Get Rating) and Aridis Pharmaceuticals (NASDAQ:ARDS – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, institutional ownership, earnings, risk and profitability. Institutional and Insider Ownership 48.9% of Veru shares are held […]

Veru (NASDAQ:VERU – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued to clients and investors on Wednesday, Benzinga reports. They presently have a $6.00 price objective on the stock. Separately, Oppenheimer reduced their price target on shares of Veru from $14.00 to $9.00 and set an “outperform” […]

Shares of Veru Inc. (NASDAQ:VERU – Get Rating) have earned an average rating of “Buy” from the seven research firms that are presently covering the firm, MarketBeat reports. Four analysts have rated the stock with a buy rating. The average 12-month price objective among brokers that have issued ratings on the stock in the last […]

Veru (NASDAQ:VERU – Get Rating) had its price objective decreased by equities research analysts at HC Wainwright from $18.00 to $14.00 in a research report issued to clients and investors on Friday, The Fly reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective would suggest a potential upside of […]

Shares of Veru Inc. (NASDAQ:VERU – Get Rating) have earned an average rating of “Buy” from the seven brokerages that are presently covering the stock, Marketbeat Ratings reports. Four analysts have rated the stock with a buy rating. The average 1-year price objective among analysts that have issued a report on the stock in the […]